HopeStage
Back to all studies
CompletedNCT00938743

Atomoxetine and driving in adults with ADHD

About this titleRead the official source — NCT00938743
Medication studyAges 18–55Germany
The study in practice

Understand this study

Who was this study for?

This study was for people with ADHD. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Listed locations
MannheimSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2008
Recruitment status
Completed
Enrollment listed in the registry
50
Sponsor
Central Institute of Mental Health, Mannheim
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Germany
Age range
From 18 Years to 55 Years
Official registry ID
NCT00938743
Official title
Show the full official title

Driving Ability in Adults With ADHD Before and After 10-weeks of Treatment With 40-80mg Atomoxetine vs. Untreated Adults With ADHD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Mannheim

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Central Institute of Mental Health, Mannheim, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Atomoxetine.

Who was this study for?

This study was for people with ADHD. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies